Navigation Links
Frantz Medical Group Announces the Promotion of Stephanie Harrington to Chief Operating Officer
Date:5/9/2011

CLEVELAND, May 9, 2011 /PRNewswire/ -- Mentor, Ohio-based Frantz Medical Group announced the immediate promotion of Stephanie A. S. Harrington, M.S. to Chief Operating Officer.  Ms. Harrington joined Frantz Medical Group in 2005 as Vice President, Research & Business Development. Since that time, she has assumed increased responsibilities such as direct management of regulatory affairs and quality assurance, manufacturing and molding/tool room operations. Ms. Harrington has also served as the Chief Operating Officer for VasoStar (cardiovascular minimally invasive device to open arterial blockages), CardioStar (non-invasive blood pressure monitor) and NanoMed (cardiovascular stent surface technology), and the Vice President of Merlot Orthopedics (orthopedic fixation devices).  Each of these companies is a Frantz Medical joint venture/equity company, and she will continue to directly manage these various operations.

Ms. Harrington is a Chemical Engineer with an undergraduate degree from the University of Maryland, and graduate degree from Stanford University.  She has been focused in the medical device field for the past 16 years with extensive experience in new product development, regulatory affairs and quality assurance. She has previously held senior management positions at Imalux and STERIS.

Ms. Harrington has spearheaded the cardiovascular and orthopedic R&D initiatives at Frantz Medical Group, including industrial-sponsored and state and national funded research grants with leading institutional partners such as Cleveland Clinic, Global Cardiovascular Innovation Center, Stanford University, and University of Virginia. Ms. Harrington will be involved in all operational aspects for the Frantz Medical Group of companies, including Frantz Tool & Design, and will serve as an advisor for tactical and strategic input on Frantz Medical Group's bioscience seed initiatives.

"I highly value Stephanie's input and leadership in all aspects of our operations, and look forward to her even further expanded role as my colleague in Frantz Medical Group," said Mark G. Frantz, Chairman and CEO.

About Frantz Medical Group

Frantz Medical Group (FMG) has been transforming innovative concepts into commercially successful medical devices, both electromechanical and disposable products, since 1979.   As an ISO 13485-certified, FDA-registered medical device company, FMG offers inventors and early-stage companies the infrastructure to design, verify, and transfer to production new medical devices efficiently and cost-effectively.   FMG's manufacturing capabilities include high-volume injection molding, assembly, inspection, and packaging – with both clean room and open manufacturing areas.   For high volume products, FMG designs products for later-stage automation, and has implemented in-house automation, lowering labor requirements and per-piece costs.

For further information regarding Frantz Medical Group, please refer to the website: www.frantzgroup.com.


'/>"/>
SOURCE Frantz Medical Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Moffitt Cancer Center Signs Licensing Agreement with Frantz BioMarkers, LLC
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Globus Medical Raises $110 Million in Series E Financing Round
6. Quark Pharmaceuticals Appoints New Chief Medical Officer
7. Boston University Biomedical Engineers Find Chink in Bacterias Armor
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
10. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
11. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... 2016  Increasingly, health care professionals are enhancing patient ... wireless technology. With the Vios Monitoring System from Vios ... remotely detect problems before they become serious by continuously ... the United States . ... --> The Vios Monitoring System connects ...
(Date:2/9/2016)... Feb. 9, 2016  Johnson & Johnson (NYSE: ... Global Healthcare Conference on Tuesday, Feb. 23, at the ... Caruso , Vice President, Finance & Chief Financial Officer ... represent the Company in a session scheduled at 10:00 ... --> www.investor.jnj.com . --> This webcast ...
(Date:2/9/2016)... , Feb. 9, 2016 Athenex, Inc. announced ... as Vice President of Corporate Strategy and Business Development based ... MBA has joined as Senior Director and Deputy Head of Clinical Research ... . Simon Pedder stated, "Athenex has a ... a while. Coupled together with their unique business model and ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... Anxiety of older Americans over ... of Medicare Part D a decade ago, according to The Senior Citizens League ... on how they are coping with rapidly rising costs. “The implications are chilling, ...
(Date:2/10/2016)... ... February 09, 2016 , ... According to a recent ... dramatic increase in the number of patients under the age of 30. According to ... seeing in their offices, and may indicate an overall shift in the rapidly growing ...
(Date:2/9/2016)... Nevada (PRWEB) , ... February 09, 2016 , ... ... providing treatment to Medicaid beneficiaries who are diagnosed with autism spectrum disorder (ASD). ... Nevada. Autism treatment using applied behavior analysis (ABA) is key to providing ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... compensation fee schedule rates and Medicare rates for a variety of medical services ... report, Evaluation of the 2015 Fee Schedule Rates in Illinois, are ...
(Date:2/9/2016)... NY (PRWEB) , ... February 09, 2016 , ... Establishment ... appointment of Dr. David Hung to the company´s Board of Directors. , ... world class scientist and an exceptional entrepreneur.” said Juan Jose Chacon Quiros, CEO of ...
Breaking Medicine News(10 mins):